Subu Ramachandran - 03 Nov 2026 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Nov 2026, 19:05:48 UTC
Prior SEC filing
05 Nov 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Sean D. Mersten, Attorney in Fact for Subu Ramachandran
Filing notes and source

Key filing fact

Subu Ramachandran filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 05 Nov 2026.

Key facts

  • This page summarizes Subu Ramachandran's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 05 Nov 2026, 19:05.

Change

  • Previous filing in this sequence was filed on 05 Nov 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002160584 Primary reporting owner

Ramachandran Subu

Relationship
SVP, Regional Businesses
Address
500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS
Signature
Sean D. Mersten, Attorney in Fact for Subu Ramachandran
Signature date
05 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DGX transaction

Common Stock

Award

Transaction value
Shares
+352
Change %
+14%
Price
$0.000000*
Shares after
2,832
Date
03 Nov 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DGX transaction Derivative

Non-Qualifed Stock Option (right to buy)

Award

Transaction value
Shares
+1,386
Change %
Price
$0.000000*
Shares after
1,386
Date
03 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,386
Exercise price
$248.61
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents an award of restricted share units.

Footnote F2

The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .